Eisai Co Ltd - Company Profile
Powered by
All the data and insights you need on Eisai Co Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date Eisai Co Ltd Strategy Report
- Understand Eisai Co Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Eisai Co Ltd’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
31 Mar 2022 | Eisai Acquires Majority Stake in Arteryex | Acquisition |
Eisai Co Ltd
|
Arteryex Co Ltd
|
01 Mar 2022 | Pathalys Pharma Enters into Licensing Agreement with EA Pharma | Licensing Agreement |
Pathalys Pharma Inc
|
EA Pharma Co Ltd
|
27 Jan 2022 | Ractigen Therapeutics Raises Additional USD30 Million in Series A+ Financing | Venture Financing |
Eisai Co Ltd
Xianghe Capital Co Ltd
SDIC Venture Capital Management Co Ltd
Soochow CSSD Capital Markets (Asia) Pte Ltd
LC Ventures (China)
|
Ractigen Therapeutics Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer